You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ureteral Neoplasms

Showing 1 - 25 of 1,017
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Combined Postoperative Radiotherapy With Kidney Sparing Surgery

Recruiting
  • Locally Advanced
  • Urothelial Carcinoma Ureter
  • Radical surgery
  • Kidney sparing surgery+Postoperative radiotheray
  • Beijing, China
  • +1 more
Nov 2, 2023

Renal Pelvic and Ureteral Tumors Trial in Guangzhou (rreversible electroporation (IRE), NanoKnife)

Completed
  • Renal Pelvic and Ureteral Neoplasms
  • rreversible electroporation (IRE)
  • NanoKnife
  • Guangzhou, Guangdong, China
    Biological treatment center in Fuda cancer hospital
Sep 1, 2021

Urinary Bladder Tumors, Tumor Metastasis, Ureteral Tumors Trial in New York, Myrtle Beach, Nashville (LOXO-435, Pembrolizumab)

Recruiting
  • Urinary Bladder Neoplasms
  • +2 more
  • New York, New York
  • +2 more
Jan 31, 2023

Urological Malignancies, Prostate Cancer, Renal Cell Cancer Trial in Seoul

Recruiting
  • Urological Malignancies
  • +4 more
    • Seoul, Korea, Republic of
      Yonsei Severance Hospital
    Jan 30, 2023

    Ureteral Tumors Trial in Roskilde (Lymphadenectomy in conjugation with nephroureterectomy, Nephroureterectomy without

    Recruiting
    • Ureteral Neoplasms
    • Lymphadenectomy in conjugation with nephroureterectomy
    • Nephroureterectomy without lymphadenectomy
    • Roskilde, Denmark
      Roskilde Hospital
    Sep 16, 2021

    Primary and Metastatic Tumors in Renal Cell Carcinoma and

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Immune checkpoint inhibitor targeting PD1
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Jan 27, 2023

    Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in

    Recruiting
    • Urothelial Cancer
    • +3 more
    • Sacituzumab Govitecan (SG)
    • Enfortumab vedotin-ejfv (EV)
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Sep 28, 2022

    Cancer, Urinary Obstruction, Malignancy Trial in Chicago (Ureteral Stent, Percutaneous Nephrostomy Tube Placement)

    Not yet recruiting
    • Cancer
    • +5 more
    • Ureteral Stent
    • Percutaneous Nephrostomy Tube Placement
    • Chicago, Illinois
      The University of Chicago
    Nov 28, 2022

    Renal Cell Carcinoma, Adrenal Tumor, Nonfunctioning Kidney Trial (telesurgery by domestic surgical robot)

    Not yet recruiting
    • Renal Cell Carcinoma
    • +13 more
    • telesurgery by domestic surgical robot
    • (no location specified)
    Feb 12, 2023

    A Genotype-Phenotype Urothelial Cancer Registry

    Recruiting
    • Urothelial Cancer
    • +3 more
    • saliva sample and questionaire
    • saliva sample, questionaire
    • Basking Ridge, New Jersey
    • +3 more
    Jun 2, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +13 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Jun 8, 2022

    Urothelial Carcinoma, Kidney Cancer, Ureter Cancer Trial in Toronto (drug, other, dietary supplement)

    Completed
    • Urothelial Carcinoma
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Nov 22, 2021

    Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,

    Not yet recruiting
    • Bladder Squamous Cell Carcinoma
    • +10 more
    • Biospecimen Collection
    • +5 more
    • Atlanta, Georgia
    • +3 more
    Feb 20, 2023

    Blood and Tissue Samples From Locally Recurrent or Metastatic

    Recruiting
    • Localized Renal Pelvis and Ureter Urothelial Carcinoma
    • +10 more
    • Cytology Specimen Collection Procedure
    • Laboratory Biomarker Analysis
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 21, 2021

    Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,

    Active, not recruiting
    • Hydronephrosis
    • +18 more
    • Durvalumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +18 more
    • Los Angeles, California
    • +2 more
    Jun 28, 2022

    Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)

    Active, not recruiting
    • Urothelial Carcinoma
    • +3 more
    • Biospecimen Collection
    • Los Angeles, California
    • +7 more
    Feb 14, 2022

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,

    Recruiting
    • Distal Urethral Cancer
    • +8 more
    • afatinib dimaleate
    • laboratory biomarker analysis
    • Atlanta, Georgia
    • +5 more
    Sep 24, 2021

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Not yet recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +31 more
    • Diagnostic Laboratory Biomarker Analysis
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Stage 0a Renal Pelvis and Ureter Cancer AJCC v8, Stage 0a Renal Pelvis Cancer AJCC v8, Stage 0a Ureter Cancer AJCC v8 Trial in

    Active, not recruiting
    • Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
    • +17 more
    • Gemcitabine Hydrochloride
    • Jacksonville, Florida
    • +3 more
    Jul 5, 2022

    Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

    Recruiting
    • Advanced Bladder Urothelial Carcinoma
    • +23 more
    • Riverside, California
    • +8 more
    Jul 16, 2022

    Neoadjuvant Immunotherapy of Locally Advanced Upper Urinary Tract Urothelial Carcinoma Trial in Shanghai (Tislelizumab)

    Active, not recruiting
    • Neoadjuvant Immunotherapy of Locally Advanced Upper Urinary Tract Urothelial Carcinoma
    • Shanghai, Shanghai, China
      Shanghai Renji Hospital
    Dec 12, 2020

    Neoadjuvant Therapy of Locally Advanced Upper Urinary Tract Urothelial Carcinoma Trial in Shanghai (Immunotherapy combined with

    Active, not recruiting
    • Neoadjuvant Therapy of Locally Advanced Upper Urinary Tract Urothelial Carcinoma
    • Immunotherapy combined with chemotherapy
    • Shanghai, Shanghai, China
      Shanghai Renji Hospital
    Dec 12, 2020

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +41 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 11, 2022